Research overview of L-DOPA production using a bacterial enzyme, tyrosine phenol-lyase

Proc Jpn Acad Ser B Phys Biol Sci. 2023;99(3):75-101. doi: 10.2183/pjab.99.006.

Abstract

L-DOPA is an amino acid that is used as a treatment for Parkinson's disease. A simple enzymatic synthesis method of L-DOPA had been developed using bacterial L-tyrosine phenol-lyase (Tpl). This review describes research on screening of bacterial strains, culture conditions, properties of the enzyme, reaction mechanism of the enzyme, and the reaction conditions for the production of L-DOPA. Furthermore, molecular bleeding of constitutively Tpl-overproducing strains is described, which were developed based on mutations in a DNA binding protein, TyrR, which controls the induction of tpl gene expression.

Keywords: Erwinia herbicola; Escherichia intermedia; L-DOPA; Parkinson’s disease; TyrR; tyrosine phenol-lyase.

Publication types

  • Review

MeSH terms

  • Bacteria
  • Levodopa
  • Tyrosine Phenol-Lyase* / genetics
  • Tyrosine Phenol-Lyase* / metabolism

Substances

  • Tyrosine Phenol-Lyase
  • Levodopa